According to the reports of the literature, miR-520f-3p is functional in liver cancer and GC 44, 45, and targeting of SOX9 by miR-520f-3p regulated the sensitivity to targeted therapy and cancer stem cell phenotype 44. This evidence concerns the gene SOX9 and gastric cancer.